The University of Southampton
University of Southampton Institutional Repository

Poster session. Multiple myeloma with IGH-involving del(14q): Report of 34 cases

Poster session. Multiple myeloma with IGH-involving del(14q): Report of 34 cases
Poster session. Multiple myeloma with IGH-involving del(14q): Report of 34 cases
Chromosomal translocations involving the IGH locus on 14q32 are a hallmark of B-cell malignancies. These translocations are particularly frequent in non-hyperdiploid (NHD) multiple myeloma (MM), representing approximately 50% of myeloma cases. MM-associated primary t(14q32) target at least 7 partner genes including cyclins D (CCND1, –D3), MAF transcription factors (CMAF, MAF B and A) and MMSET/FGFR3. Some of the translocations are predictive of clinical outcome. Recently, we identified a novel interstitial del(14q) involving IGH and recurrent in chronic lymphocytic leukaemia and MM (Pospisilova et al, Leukemia, 2007). In spite of extensive studies, the mechanism(s) and molecular consequences of del(14q) remain unknown. We report here 34 cases of plasma cell (PC) malignancies with del(14q) involving IGH, as proven by FISH. Cases were collected in UK and Belgium. The estimated incidence of these aberrations in PC malignancies was 1.4%. There were 13 female and 21 male patients ranging in age from 49 to 86 years (average 68). Twenty seven patients had MM, one had SMM and 6 had MGUS. In almost all cases, the del(14q) was detected at diagnosis. Clinical data of the reported cases have been collected. The del(14q) were roughly mapped by FISH and grouped into 3 categories according to the proximal breakpoint:
1. del(14)(q24.1q32.33) involving the ZFP36L1 region (11 cases);
2. deletions proximal to ZFP36L1 (14 cases) and
3. deletions distal to ZFP36L1 (7 cases).
The size of del(14q) was not determined in 2 cases. Biallelic deletion of TRAF3/14q32.33 recurrently occurring in MM, was detected by FISH in 1 out of 9 analyzed cases. Additional FISH analysis showed that the del(14q) was predominantly associated with NHD tumors (62% vs 38% with hyperdiploid karyotypes) and frequently (60%) accompanied by del(13q), regarded as a poor prognostic factor. All reported cases were negative for t(4;14) and t(11;14); they also showed a normal status of CCND3, CMAF, MAFB and CMYC, when examined. A gain of 1q/CKS1B was found in 57% (8/14) of analyzed cases. The expression pattern of cyclin D1–D3 has been examined.
time, belgium, hematology, multiple myeloma, england, human, report
0006-4971
p.301A
Wlodarska, Iwona
43a4d401-64a8-476a-8ff9-416363712f2e
Ross, Fiona M.
08e9ce4d-608a-413f-b9bf-95cdfa24186e
Russell, Lisa J.
cd43806b-dc23-4a75-a263-eb7a4ab90f92
Pospisilova, Helena
2a5a7913-58d0-4eb4-a0b3-8eb9558e561a
Chiecehio, Laura
233ddabf-e106-4568-bc36-9f008f0be111
Van Caillie, Marie-Astrid
66d66057-ac85-4d23-912b-3046d0cbfd09
Dagrada, GianPaolo
a149df7d-0de2-487d-8697-0a8913b998cd
De Wolf-Peeters, Christiane
3b2bbd7f-ff3f-4224-9a55-d8f68e3a81af
Harrison, Christine J.
52da7673-509c-4b88-b92e-0c021c9c7d3e
De Paepe, Pascale
0264ce1e-53f1-4a83-9b3c-8081cf048604
Vandenberghe, Peter
f722b2a9-0680-4d27-9342-a16de8467c69
Michaux, Lucienne
40729cf4-3457-480b-a30d-1b08f686d92d
Wlodarska, Iwona
43a4d401-64a8-476a-8ff9-416363712f2e
Ross, Fiona M.
08e9ce4d-608a-413f-b9bf-95cdfa24186e
Russell, Lisa J.
cd43806b-dc23-4a75-a263-eb7a4ab90f92
Pospisilova, Helena
2a5a7913-58d0-4eb4-a0b3-8eb9558e561a
Chiecehio, Laura
233ddabf-e106-4568-bc36-9f008f0be111
Van Caillie, Marie-Astrid
66d66057-ac85-4d23-912b-3046d0cbfd09
Dagrada, GianPaolo
a149df7d-0de2-487d-8697-0a8913b998cd
De Wolf-Peeters, Christiane
3b2bbd7f-ff3f-4224-9a55-d8f68e3a81af
Harrison, Christine J.
52da7673-509c-4b88-b92e-0c021c9c7d3e
De Paepe, Pascale
0264ce1e-53f1-4a83-9b3c-8081cf048604
Vandenberghe, Peter
f722b2a9-0680-4d27-9342-a16de8467c69
Michaux, Lucienne
40729cf4-3457-480b-a30d-1b08f686d92d

Wlodarska, Iwona, Ross, Fiona M., Russell, Lisa J., Pospisilova, Helena, Chiecehio, Laura, Van Caillie, Marie-Astrid, Dagrada, GianPaolo, De Wolf-Peeters, Christiane, Harrison, Christine J., De Paepe, Pascale, Vandenberghe, Peter and Michaux, Lucienne (2007) Poster session. Multiple myeloma with IGH-involving del(14q): Report of 34 cases. Blood, 110 (11), p.301A.

Record type: Article

Abstract

Chromosomal translocations involving the IGH locus on 14q32 are a hallmark of B-cell malignancies. These translocations are particularly frequent in non-hyperdiploid (NHD) multiple myeloma (MM), representing approximately 50% of myeloma cases. MM-associated primary t(14q32) target at least 7 partner genes including cyclins D (CCND1, –D3), MAF transcription factors (CMAF, MAF B and A) and MMSET/FGFR3. Some of the translocations are predictive of clinical outcome. Recently, we identified a novel interstitial del(14q) involving IGH and recurrent in chronic lymphocytic leukaemia and MM (Pospisilova et al, Leukemia, 2007). In spite of extensive studies, the mechanism(s) and molecular consequences of del(14q) remain unknown. We report here 34 cases of plasma cell (PC) malignancies with del(14q) involving IGH, as proven by FISH. Cases were collected in UK and Belgium. The estimated incidence of these aberrations in PC malignancies was 1.4%. There were 13 female and 21 male patients ranging in age from 49 to 86 years (average 68). Twenty seven patients had MM, one had SMM and 6 had MGUS. In almost all cases, the del(14q) was detected at diagnosis. Clinical data of the reported cases have been collected. The del(14q) were roughly mapped by FISH and grouped into 3 categories according to the proximal breakpoint:
1. del(14)(q24.1q32.33) involving the ZFP36L1 region (11 cases);
2. deletions proximal to ZFP36L1 (14 cases) and
3. deletions distal to ZFP36L1 (7 cases).
The size of del(14q) was not determined in 2 cases. Biallelic deletion of TRAF3/14q32.33 recurrently occurring in MM, was detected by FISH in 1 out of 9 analyzed cases. Additional FISH analysis showed that the del(14q) was predominantly associated with NHD tumors (62% vs 38% with hyperdiploid karyotypes) and frequently (60%) accompanied by del(13q), regarded as a poor prognostic factor. All reported cases were negative for t(4;14) and t(11;14); they also showed a normal status of CCND3, CMAF, MAFB and CMYC, when examined. A gain of 1q/CKS1B was found in 57% (8/14) of analyzed cases. The expression pattern of cyclin D1–D3 has been examined.

This record has no associated files available for download.

More information

Published date: 16 November 2007
Additional Information: ASH Annual Meeting Abstracts 2007: abstract 991
Keywords: time, belgium, hematology, multiple myeloma, england, human, report

Identifiers

Local EPrints ID: 60437
URI: http://eprints.soton.ac.uk/id/eprint/60437
ISSN: 0006-4971
PURE UUID: 18a3af2f-e5df-4ac0-b65c-8e876b878e51

Catalogue record

Date deposited: 07 Nov 2008
Last modified: 22 Jul 2022 21:12

Export record

Contributors

Author: Iwona Wlodarska
Author: Fiona M. Ross
Author: Lisa J. Russell
Author: Helena Pospisilova
Author: Laura Chiecehio
Author: Marie-Astrid Van Caillie
Author: GianPaolo Dagrada
Author: Christiane De Wolf-Peeters
Author: Christine J. Harrison
Author: Pascale De Paepe
Author: Peter Vandenberghe
Author: Lucienne Michaux

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×